Meeting Report
Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma: Highlights From SOHO 2021
Kelly Valla, PharmD, BCOP
J Adv Pract Oncol 2022;13(suppl 1):37–40 |
https://doi.org/10.6004/jadpro.2022.13.1.18 |
© 2022 Harborside™
ABSTRACT
Kelly Valla, PharmD, BCOP, of Winship Cancer Institute of Emory University, evaluates novel treatment approaches in relapsed/refractory mantle cell lymphoma, as presented by Kami J. Maddocks, MD, of Ohio State University, at the 2021 SOHO Annual Meeting.
For access to the full length article, please
sign in.